Swissmedic - Swiss Agency for Therapeutic Products

Swissmedic is the regulatory agency responsible for authorizing and supervising therapeutic products in Switzerland. Based in Bern, the agency started its activities on 1 January 2012, replacing the Interkantonale Kontrollstelle für Heilmittel (IKS). It was created by the Federal Act on Medicinal Products and Medical Devices and is attached to the Federal Department of Home Affairs, but functions as a autonomous agency with its own budget.

Swissmedic is responsible for the authorization of health products, and for licensing their manufacturing and wholesale. It also deals with clinical trials, establishing standards, and monitoring these products on the market.

Within the UL family of companies we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brands, UL is unable to provide consultancy services to Notified Body or MDSAP customers. UL has processes in place to identify and manage any potential conflicts of interest and maintain impartiality. Learn more here.